Stay updated on Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial page.

Latest updates to the Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 to the history and removed the prior government funding lapse notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check20 days agoChange DetectedAdded a general site status notice about government funding and updated the revision tag to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check28 days agoChange DetectedThe history page introduces UI-related updates: a Show glossary option and color-coded indicators for additions and deletions, along with a new Revision: v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check42 days agoChange DetectedThe history now includes a new revision entry v3.3.4, updating the record's version history and replacing the previous v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history shows a revision on 2025-12-22 (Revision: v3.3.3) that adds Active, not recruiting and updates core sections (Contacts/Locations, Study Design, Study Status, Study Identification, Recruitment Status). A prior revision on 2024-10-30 (Revision: v3.3.2) removed the term 'Recruiting' and the HHS Vulnerability Disclosure.SummaryDifference0.8%

- Check92 days agoChange DetectedFooter revision tag updated from v3.2.0 to v3.3.2. The rest of the page content and layout remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial page.